Terapia cognitivo conductual para calidad de vida en pacientes con cáncer de próstata, una revisión narrativa de la literatura
DOI:
https://doi.org/10.48193/revistamexicanadeurologa.v83i5.937Palabras clave:
Cáncer de próstata, Calidad de Vida, Terapia cognitivo conductual, Revisión, tratamiento psicológicoResumen
Introducción: el cáncer de próstata (CaP) tiene alta incidencia a nivel mundial, genera diversas alteraciones en los pacientes, por ello es importante evaluar si la terapia cognitivo conductual (TCC) puede resultar efectiva para mejorar su calidad de vida (CaV).
Objetivo: conocer los efectos de la TCC sobre la CaV en pacientes con cáncer de próstata.
Métodos: se revisaron las bases de datos Medline, APA PsycInfo, Web of Science y Biblioteca Cochrane, mediante la metodología PIO, se utilizaron términos MESH, text words y booleanos para realizar los cruces, del año 2000 a 2020.
Resultados: se identificaron 800 artículos de los cuales se analizaron los resultados de 11 publicaciones con texto completo en los que se evidenció la aplicación de la TCC. Se encontró que tiene efectos positivos en la CaV; además se identificó la modalidad, las variables evaluadas y las técnicas empleadas en el tratamiento.
Conclusiones: La evidencia disponible sugiere que es necesario extender el empleo de la TCC para mejorar la CaV de los pacientes con CaP, además de desarrollar estas investigaciones en otras poblaciones, por ejemplo, pacientes latinoamericanos.
Referencias
Chhikara B, Parang K. Global Cancer Statistics 2022: The Trends Projection Analysis. Pharmacy Faculty Articles and Research. 2022;10(1).
Miller KD, Ortiz AP, Pinheiro PS, Bandi P, Minihan A, Fuchs HE, et al. Cancer statistics for the US Hispanic/Latino population, 2021. CA A Cancer J Clinicians. 2021;71(6):466–87. doi: https://doi.org/10.3322/caac.21695
The Whoqol Group. The World Health Organization quality of life assessment (WHOQOL): Development and general psychometric properties. Social Science & Medicine. 1998;46(12):1569–85. doi: https://doi.org/10.1016/S0277-9536(98)00009-4
Cella DF. Measuring quality of life in palliative care. Semin Oncol. 1995;22(2 Suppl 3):73–81.
Urzúa M A. Calidad de vida relacionada con la salud: Elementos conceptuales. Revista médica de Chile. 2010;138(3):358–65. doi: http://dx.doi.org/10.4067/S0034-98872010000300017
Monga U, Kerrigan AJ, Thornby J, Monga TN, Zimmermann KP. Longitudinal study of quality of life in patients with localized prostate cancer undergoing radiotherapy. J Rehabil Res Dev. 2005;42(3):391–9. doi: https://doi.org/10.1682/jrrd.2004.06.0071
Chen RC, Chang P, Vetter RJ, Lukka H, Stokes WA, Sanda MG, et al. Recommended Patient-Reported Core Set of Symptoms to Measure in Prostate Cancer Treatment Trials. JNCI: Journal of the National Cancer Institute. 2014;106(7). doi: https://doi.org/10.1093/jnci/dju132
Watts S, Leydon G, Birch B, Prescott P, Lai L, Eardley S, et al. Depression and anxiety in prostate cancer: a systematic review and meta-analysis of prevalence rates. BMJ Open. 2014;4(3):e003901. doi: https://doi.org/10.1136/bmjopen-2013-003901
Espinoza Bello M, Galindo Vázquez O, Jiménez Ríos M A, Lerma Talamantes A, Acosta Santos N, Álvarez Avitia M A, et al. Factores predictores de sintomatología de ansiedad, depresión y calidad de vida global en pacientes mexicanos con cáncer de próstata. Psicología y Salud. 2020;30(2):141–52. doi: https://doi.org/10.25009/pys.v30i2.2649
Bourke L, Boorjian SA, Briganti A, Klotz L, Mucci L, Resnick MJ, et al. Survivorship and Improving Quality of Life in Men with Prostate Cancer. European Urology. 2015;68(3):374–83. doi: https://doi.org/10.1016/j.eururo.2015.04.023
Espinoza-Bello M, Galindo-Vázquez Ó, Jiménez-Ríos MA, Lerma A, Acosta-Santos NA, Meneses-García AA, et al. Propiedades psicométricas de la Escala de Evaluación Funcional para el Tratamiento del Cáncer, versión próstata (FACT-P), en pacientes mexicanos. CIRU. 2020;88(6):4913. doi: https://doi.org/10.24875/ciru.19001755
American Psychological Association. cognitive behavior therapy (CBT). In: APA Dictionary of Psychology. 2018. [accessed 3 Oct 2023] Available from: https://dictionary.apa.org/
Galindo Vázquez O, Pérez Barrientos H, Alvarado Aguilar S, Rojas Castillo E, Alvarez Avitia MA, Aguilar Ponce JL. Efectos de la terapia cognitivo conductual en el paciente oncológico: una revisión. Gaceta mexicana de oncología. 2013;12(2):108–15.
Johnson JA, Rash JA, Campbell TS, Savard J, Gehrman PR, Perlis M, et al. A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev. 2016;27:20–8. doi: https://doi.org/10.1016/j.smrv.2015.07.001
Ye M, Du K, Zhou J, Zhou Q, Shou M, Hu B, et al. A meta‐analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients. Psycho-Oncology. 2018;27(7):1695–703. doi: https://doi.org/10.1002/pon.4687
Redd WH, Montgomery GH, DuHamel KN. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst. 2001;93(11):810–23. doi: https://doi.org/10.1093/jnci/93.11.810
Meng FP, Zhou LN. Positive role of cognitive-behavioral therapy on sexual dysfunction and behavioral problems in prostate cancer-treated patients. J Biol Regul Homeost Agents. 2020;34(3):1049–52. doi: roto
Getu MA, Chen C, Panpan W, Mboineki JF, Dhakal K, Du R. The effect of cognitive behavioral therapy on the quality of life of breast cancer patients: a systematic review and meta-analysis of randomized controlled trials. Qual Life Res. 2021;30(2):367–84. doi: https://doi.org/10.1007/s11136-020-02665-5
Peoples AR, Garland SN, Perlis ML, Savard J, Heckler CE, Kamen CS, et al. Effects of Cognitive Behavioral Therapy for Insomnia and Armodafinil on Quality of Life in Cancer Survivors: A Randomized Placebo-Controlled Trial. J Cancer Surviv. 2017;11(3):401–9. doi: https://doi.org/10.1007/s11764-017-0597-0
Landa-Ramírez E, Arredondo-Pantaleón A de J. Herramienta pico para la formulación y busqueda de preguntas clínicamente relevantes en la psicooncología basada en el evidencia. Psicooncología (Pozuelo de Alarcón). 2014;259–70.
Lepore SJ, Helgeson VS, Eton DT, Schulz R. Improving quality of life in men with prostate cancer: A randomized controlled trial of group education interventions. Health Psychology. 2003;22(5):443–52. doi: https://doi.org/10.1037/0278-6133.22.5.443
Penedo FJ, Dahn JR, Molton I, Gonzalez JS, Kinsinger D, Roos BA, et al. Cognitive-behavioral stress management improves stress-management skills and quality of life in men recovering from treatment of prostate carcinoma. Cancer. 2004;100(1):192–200. doi: https://doi.org/10.1002/cncr.11894
Penedo FJ, Molton I, Dahn JR, Shen B-J, Kinsinger D, Traeger L, et al. A randomized clinical trial of group-based cognitive-behavioral stress management in localized prostate cancer: Development of stress management skills improves quality of life and benefit finding. Annals of Behavioral Medicine. 2006;31(3):261–70. doi: https://doi.org/10.1207/s15324796abm3103_8
Daubenmier JJ, Weidner G, Marlin R, Crutchfield L, Dunn-Emke S, Chi C, et al. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance. Urology. 2006;67(1):125–30. doi: https://doi.org/10.1016/j.urology.2005.07.056
Penedo FJ, Traeger L, Dahn J, Molton I, Gonzalez JS, Schneiderman N, et al. Cognitive behavioral stress management intervention improves quality of life in spanish monolingual hispanic men treated for localized prostate cancer: Results of a randomized controlled trial. Int J Behav Med. 2007;14(3):164–72. doi: https://doi.org/10.1007/bf03000188
Parker PA, Pettaway CA, Babaian RJ, Pisters LL, Miles B, Fortier A, et al. The Effects of a Presurgical Stress Management Intervention for Men With Prostate Cancer Undergoing Radical Prostatectomy. JCO. 2009;27(19):3169–76. doi: https://doi.org/10.1200/jco.2007.16.0036
Traeger L, Penedo FJ, Benedict C, Dahn JR, Lechner SC, Schneiderman N, et al. Identifying how and for whom cognitive-behavioral stress management improves emotional well-being among recent prostate cancer survivors: CBSM and emotional well-being. Psycho-Oncology. 2011;n/a-n/a. doi: https://doi.org/10.1002/pon.2074
Yanez B, McGinty HL, Mohr DC, Begale MJ, Dahn JR, Flury S, et al. Feasibility, acceptability, and preliminary efficacy of a technology-assisted psychosocial intervention for racially diverse men with advanced prostate cancer. Cancer. 2015;121(24):4407–15. doi: https://doi.org/10.1002/cncr.29658
Stefanopoulou E, Yousaf O, Grunfeld EA, Hunter MS. A randomised controlled trial of a brief cognitive behavioural intervention for men who have hot flushes following prostate cancer treatment (MANCAN). Psycho‐Oncology. 2015;24(9):1159–66. doi: https://doi.org/10.1002/pon.3794
Chambers SK, Occhipinti S, Foley E, Clutton S, Legg M, Berry M, et al. Mindfulness-Based Cognitive Therapy in Advanced Prostate Cancer: A Randomized Controlled Trial. J Clin Oncol. 2017;35(3):291–7. doi: https://doi.org/10.1200/jco.2016.68.8788
Burlingame GM, Strauss B, Joyce AS. Change mechanisms and effectiveness of small group treatments. In: Bergin and Garfield’s Handbook of Psychotherapy and Behavior Change. Wiley; 2013.
Descargas
Publicado
Número
Sección
Licencia
Derechos de autor 2023 Revista Mexicana de Urología
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
